As shown in Figure 6A–6C, the greatest increase in tumor volume and weight was observed after treatment with E2, and this trend might be associated with the significant upregulation of RP11-65M17.3 and ERα expression in the xenografts (p < 0.05). The gene discussed is ESR1; the disease is neoplasm.